Effects of Human Milk Whey Proteins on PPARγ Gene Expression and Cell Migration in Gastric Cancer Cell Line

Yıl 2025, Cilt: 6 Sayı: 4, 298 - 310, 31.12.2025

Demet Baldız Dinç , Ceyda Okudu

https://doi.org/10.46871/eams.1797797

Öz

Purpose: Human breast milk, a source of biologically active molecules, has long been utilized in the treatment of various diseases. Among its components, whey proteins have attracted attention for their potential influence on cancer-related metabolic pathways, particularly peroxisome proliferator-activated receptor gamma (PPARγ), a key regulator of tumor progression. The present study aimed to investigate the effects of human milk-derived whey proteins on PPARγ gene expression and cell migration in gastric cancer cells.
Methods: Whey proteins were isolated from breast milk collected from ten mothers with infants aged 0–6 months and applied to AGS gastric cancer cells under laboratory conditions. After 48 hours of incubation, total RNA was extracted, reverse-transcribed to cDNA, and PPARγ expression levels were quantified using qRT-PCR. In parallel, cell migration was evaluated through wound healing assays.
Results: The results indicated differential regulation of PPARγ expression across samples. A significant increase in expression was observed in samples 3, 4, 5, 6, and 7 (p<0.05), whereas sample 8 was the only group showing decreased expression. Migration assays further revealed that whey proteins from samples 2, 3, 5, and 8 suppressed cell migration relative to controls, while samples 6, 7, 9, and 10 did not exhibit such effects.
Conclusion: Overall, these findings suggest that whey proteins from different individuals exert variable effects on PPARγ expression and gastric cancer cell migration, potentially reflecting inter-individual differences in protein composition. Future studies should focus on characterizing individual protein components of whey and their specific contributions to PPARγ regulation and metastasis-related pathways.

Anahtar Kelimeler

cell migration , gastric cancer , PPARγ , whey proteins

Etik Beyan

Ethical approval was obtained from the Haliç University Non-Interventional Clinical Trials Ethics Committee for the collection of breast milk as the material to be analyzed in the study (01/12/2021-194).

Teşekkür

I would like to thank Özlem Ağırel for her contributions to the completion of this study.

Mide Kanseri Hücre Hattında İnsan Sütü Whey proteinlerinin PPARγ Gen Ekspresyonu ve Hücre Göçü Üzerindeki Etkileri

Öz

Amaç: Biyolojik açıdan oldukça önemli moleküllere sahip olan insan anne sütünün yüzyıllardır birçok hastalığın tedavisinde kullanıldığı bilinmektedir. Kanser progresyonundaki kilit metabolik yolaklardan biri olan PPARγ’ nın anne sütü whey proteinleri uygulandığında nasıl bir etkiye sebep olduğu hala araştırılmaktadır. Bu çalışmada anne sütünden elde edilen whey proteinleri uygulanan mide kanseri hücrelerinde kanserleşme sürecinde kompleks etkisi olan PPARγ’ nın gen ifadesi ve hücre göçü üzerindeki etkisinin incelenmesi amaçlandı.
Yöntem: 0-6 aylık bebeği olan 10 farklı anneden alınan sütlerden laboratuvar koşullarında whey proteinleri elde edilerek uygun koşullarda çoğaltılmış olan AGS mide kanseri hücrelerine uygulandı. 48 saat inkübasyonu takiben total RNA izolasyonunu takiben cDNA sentezi yapılarak qRT-PCR yöntemi ile PPARγ gen ifadesi değerlendirildi. Ayrıca yara iyileşme deneyi ile hücre göçü analiz edildi.
Bulgular: 1 ile 10 arasında numaralandırılan anne sütlerinden sadece 8. örnekte PPARγ gen ifadesinde azalma görüldü. Diğer örneklerde PPARγ gen ifadesinde artış tespit edildi ancak 3., 4., 5., 6. ve 7. örneklerde bu artış istatistiksel olarak anlamlı bulundu (p<0.05). Hücre göçü analizinde ise kontrol hücre grbu ile karşılaştırıldığında 2., 3., 5., ve 8. anne sütü whey proteinlerinin baskıladığı, 6., 7., 9., 10. anne sütü whey proteinlerinin ise metastazı baskılamadığı tespit edildi.
Sonuç: Bu çalışma ile farklı annelerden elde edilen whey proteinlerinin PPARγ ifadesini farklı düzenlediği ve bunun metastatik yolaklarla ilişkili olduğu ortaya kondu. Bu durum whey proteinlerinin kişiden kişiye farklı protein profili içermesi ile ilişkilendirilebilir. Whey proteini kompozisyonunu oluşturan her bir proteinin PPARγ ve hücre göçü üzerindeki etkisi tek tek değerlendirilmelidir.

Anahtar Kelimeler

hücre göçü , mide kanser , PPARγ , whey proteinleri

Etik Beyan

Çalışmada analiz edilen materyal olarak anne sütü toplanması için Haliç Üniversitesi Girişimsel Olmayan Klinik Araştırmalar Etik Kurulu'ndan etik onay alındı ​​(01/12/2021-194).

Teşekkür

Bu çalışmanın tamamlanmasındaki katkılarından dolayı Özlem Ağırel' e teşekkürlerimi sunarım.

Kaynakça

• 1. Demirtaş MS, Yalçın SS. The use of human milk for therapeutic purposes other than nutrition. Turk Arch Pediatr. 2022;57(3):255-66.
• 2. Witkowska-Zimny M, Kamińska-El-Hassan E, Wróbel E. Milk therapy: unexpected uses for human breast milk. Nutrients. 2019;11(5):944.
• 3. Teixeira FJ, Santos HO, Howell SL et al. Whey protein in cancer therapy: a narrative review. Pharmacol Res. 2019; 144:245-56.
• 4. Hong S, Dia VP, Baek SJ et al. Nanoencapsulation of apigenin with whey protein isolate: physicochemical properties, in vitro activity against colorectal cancer cells, and bioavailability. LWT. 2022; 154:112751-61.
• 5. Singh S, Maurya P, Rani S et al. Development of doxorubicin hydrochloride–loaded whey protein nanoparticles and its surface modification with N-acetyl cysteine for triple-negative breast cancer. Drug Deliv Transl Res. 2022;12(12):3047-62.
• 6. Murali C, Mudgil P, Gan CY et al. Camel whey protein hydrolysates induced G2/M cell-cycle arrest in human colorectal carcinoma. Sci Rep. 2021;11(1):7062-76.
• 7. Sahna KO, Cakir B, Tunali-Akbay T. Antiproliferative activity of whey and casein bioactive peptides on breast cancer: an in vitro and in silico study. Int J Pept Res Ther. 2022;28(4):128-40.
• 8. Ramani A, Hazra T, Mudgil S et al. Emerging potential of whey proteins in prevention of cancer. Food Human. 2024; 2:100199-208.
• 9. Marcone S, Haughton K, Simpson PJ et al. Milk-derived bioactive peptides inhibit human endothelial–monocyte interactions via PPAR-γ-dependent regulation of NF-κB. J Inflamm. 2015;12(1):1-28.
• 10. Xie K, He D, Zhao T et al. Gastric cancer with sarcopenia: an area worth focusing on. Curr Treat Options Oncol. 2023;24(10):1305-27.
• 11. Chen QY, Huang XB, Zhao YJ et al. The PPAR agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer. Theranostics. 2022;12(4):1904-18.
• 12. Yamamoto K, Tamura T, Nakamura R et al. Development of a novel class of PPAR-γ ligands as an anticancer agent with a unique binding mode based on a non-thiazolidinedionescaffold. Bioorg Med Chem. 2019;27(22):115122-39.
• 13. Cheng HS, Yip YS, Lim EKY et al. PPARs and tumor microenvironment: emerging roles of metabolic master regulators in stromal–epithelial crosstalk and carcinogenesis. Cancers. 2021;13(9):2153-78.
• 14. Asgharzadeh F, Memarzia A, Alikhani V et al. Peroxisome proliferator-activated receptors: key regulators of tumor progression and growth. Transl Oncol. 2024; 47:102039-60.
• 15. Liu Y, Tang L, Peng B et al. Gastric cancer adapts to a high-lipid microenvironment via suppressing the PPARG–FABP1 axis after arriving in the lymph node. Redox Biol. 2025;103759.
• 16. Liu L, Si N, Ma Y et al. Hydroxysafflor-yellow A induces human gastric carcinoma BGC-823 cell apoptosis by activating PPAR-γ. Med Sci Monit. 2018; 24:803-11.
• 17. Minekawa R, Takeda T, Sakata M et al. Human breast milk suppresses the transcriptional regulation of IL-1β-induced NF-κB signaling in human intestinal cells. Am J Physiol Cell Physiol. 2004;287(5):C1404-11.
• 18. Xiao J, Ma J, Khan MZ et al. Unlocking the potential of milk whey protein components in colorectal cancer prevention and therapy. Crit Rev Food Sci Nutr. 2024;64(33):12961-98.
• 19. Kang NM, Cho SG, Dayem AA et al. The effects of human milk proteins on the proliferation of normal, cancer and cancer stem-like cells. Anal Sci Technol. 2018;31(6):232-39.
• 20. Thampy A, Palani Kumar MK, Serva Peddha M et al. The effectiveness of whey proteins in prevention and treatment of cancer: a review. Crit Rev Food Sci Nutr. 2024;64(8):2088-104.
• 21. D’Onofrio N, Martino E, Balestrieri A et al. SIRT3 and metabolic reprogramming mediate the antiproliferative effects of whey in human colon cancer cells. Cancers. 2021;13(20):5196-214.
• 22. Cacciola NA, Salzano A, D’Onofrio N et al. Buffalo milk whey activates necroptosis and apoptosis in a xenograft model of colorectal cancer. Int J Mol Sci. 2022;23(15):8464.
• 23. AlNafea HM, Korish AA. Activation of PPAR-α/γ and the fatty acid-metabolizing enzyme CPT1A by camel milk treatment counteracts high-fat-diet-induced nonalcoholic fatty liver disease. PPAR Res. 2021;5558731.
• 24. D’Souza K, Mercer A, Mawhinney H et al. Whey peptides stimulate differentiation and lipid metabolism in adipocytes and ameliorate lipotoxicity-induced insulin resistance in muscle cells. Nutrients. 2020;12(2):425-43.
• 25. Boga B, Akbulut M, Maytalman E et al. Effect of milk and whey on proliferation and differentiation of placental stromal cells. Cytotechnology. 2023;75(5):391-401.
• 26. Li Y, Zhang ZH, Huang SL et al. Whey protein powder with milk fat globule membrane attenuates Alzheimer’s disease pathology in 3×Tg-AD mice by modulating neuroinflammation through PPAR-γ signaling. J Dairy Sci. 2023;106(8):5253-65.
• 27. Badr G, Abdel-Tawab HS, Ramadan NK et al. Protective effects of camel whey protein against scrotal heat-mediated damage and infertility in mice through YAP/Nrf2 and PPAR-γ pathways. Mol Reprod Dev. 2018;85(6):505-18.
• 28. Yagi M, Suzuki N, Takayama T et al. Effects of lactoferrin on differentiation of pluripotent mesenchymal cells. Cell Biol Int. 2009;33(3):283-89.
• 29. Guo X, Qin M, Hong H et al. Circular RNA hsa_circ_0072309 inhibits proliferation, invasion and migration of gastric cancer cells via PI3K/AKT inhibition by activating PPARγ/PTEN signaling. Mol Med Rep. 2021;23(5):1-8.